CTI BioPharma (CTIC) Prices $35M Offering of Convertible Preferred Stock
Tweet Send to a Friend
CTI BioPharma Corp. (NASDAQ: CTIC) today announced the pricing of an underwritten public offering of 35,000 shares of its Series ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
